CN Patent
CN102250189A — 一种具有1,12-二烯-3-酮骨架的甘草次酸衍生物、其制备方法及医药用途
Assigned to China Pharmaceutical University · Expires 2011-11-23 · 14y expired
What this patent protects
本发明涉及药物领域,具体涉及一种具有1,12-二烯-3-酮骨架的甘草次酸衍生物或其药学上可接受的盐,它们的制备方法及医药用途,特别是在制备抗肿瘤药物中的应用。药理实验结果表明,该类化合物具有良好的抗肿瘤活性,临床上可用于制备抗肿瘤药物。
USPTO Abstract
本发明涉及药物领域,具体涉及一种具有1,12-二烯-3-酮骨架的甘草次酸衍生物或其药学上可接受的盐,它们的制备方法及医药用途,特别是在制备抗肿瘤药物中的应用。药理实验结果表明,该类化合物具有良好的抗肿瘤活性,临床上可用于制备抗肿瘤药物。
Drugs covered by this patent
- Skyclarys (OMAVELOXOLONE) · Biogen Us
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.